Literature DB >> 20733044

Systematic review and meta-analysis of the efficacy of appropriate empiric antibiotic therapy for sepsis.

Mical Paul1, Vered Shani, Eli Muchtar, Galia Kariv, Eyal Robenshtok, Leonard Leibovici.   

Abstract

Quantifying the benefit of early antibiotic treatment is crucial for decision making and can be assessed only in observational studies. We performed a systematic review of prospective studies reporting the effect of appropriate empirical antibiotic treatment on all-cause mortality among adult inpatients with sepsis. Two reviewers independently extracted data. Risk of bias was assessed using the Newcastle-Ottawa score. We calculated unadjusted odds ratios (ORs) with 95% confidence intervals for each study and extracted adjusted ORs, with variance, methods, and covariates being used for adjustment. ORs were pooled using random-effects meta-analysis. We examined the effects of methodological and clinical confounders on results through subgroup analysis or mixed-effect meta-regression. Seventy studies were included, of which 48 provided an adjusted OR for inappropriate empirical antibiotic treatment. Inappropriate empirical antibiotic treatment was associated with significantly higher mortality in the unadjusted and adjusted comparisons, with considerable heterogeneity occurring in both analyses (I(2) > 70%). Study design, time of mortality assessment, the reporting methods of the multivariable models, and the covariates used for adjustment were significantly associated with effect size. Septic shock was the only clinical variable significantly affecting results (it was associated with higher ORs). Studies adjusting for background conditions and sepsis severity reported a pooled adjusted OR of 1.60 (95% confidence interval = 1.37 to 1.86; 26 studies; number needed to treat to prevent one fatal outcome, 10 patients [95% confidence interval = 8 to 15]; I(2) = 46.3%) given 34% mortality with inappropriate empirical treatment. Appropriate empirical antibiotic treatment is associated with a significant reduction in all-cause mortality. However, the methods used in the observational studies significantly affect the effect size reported. Methods of observational studies assessing the effects of antibiotic treatment should be improved and standardized.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20733044      PMCID: PMC2976147          DOI: 10.1128/AAC.00627-10

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  96 in total

1.  Outcome of postoperative pneumonia in the Eole study.

Authors:  Hervé Dupont; Philippe Montravers; Rémy Gauzit; Benoît Veber; Jean-Louis Pouriat; Claude Martin
Journal:  Intensive Care Med       Date:  2003-01-14       Impact factor: 17.440

2.  Outcome in bacteremia associated with nosocomial pneumonia and the impact of pathogen prediction by tracheal surveillance cultures.

Authors:  Pieter Depuydt; Dominique Benoit; Dirk Vogelaers; Geert Claeys; Gerda Verschraegen; Koenraad Vandewoude; Johan Decruyenaere; Stijn Blot
Journal:  Intensive Care Med       Date:  2006-09-16       Impact factor: 17.440

3.  Improving empirical antibiotic treatment using TREAT, a computerized decision support system: cluster randomized trial.

Authors:  Mical Paul; Steen Andreassen; Evelina Tacconelli; Anders D Nielsen; Nadja Almanasreh; Uwe Frank; Roberto Cauda; Leonard Leibovici
Journal:  J Antimicrob Chemother       Date:  2006-09-23       Impact factor: 5.790

4.  Multiple-drug-resistant bacteria in patients with severe acute exacerbation of chronic obstructive pulmonary disease: Prevalence, risk factors, and outcome.

Authors:  Saad Nseir; Christophe Di Pompeo; Béatrice Cavestri; Elsa Jozefowicz; Martine Nyunga; Stéphane Soubrier; Micheline Roussel-Delvallez; Fabienne Saulnier; Daniel Mathieu; Alain Durocher
Journal:  Crit Care Med       Date:  2006-12       Impact factor: 7.598

Review 5.  Does antibiotic selection impact patient outcome?

Authors:  Stephan Harbarth; Vandack Nobre; Didier Pittet
Journal:  Clin Infect Dis       Date:  2006-11-27       Impact factor: 9.079

6.  Bacteremia due to Acinetobacter baumannii: epidemiology, clinical findings, and prognostic features.

Authors:  J M Cisneros; M J Reyes; J Pachón; B Becerril; F J Caballero; J L García-Garmendía; C Ortiz; A R Cobacho
Journal:  Clin Infect Dis       Date:  1996-06       Impact factor: 9.079

7.  Epidemiology and outcome of Pseudomonas aeruginosa bacteremia, with special emphasis on the influence of antibiotic treatment. Analysis of 189 episodes.

Authors:  F Vidal; J Mensa; M Almela; J A Martínez; F Marco; C Casals; J M Gatell; E Soriano; M T Jimenez de Anta
Journal:  Arch Intern Med       Date:  1996-10-14

8.  The systemic inflammatory response syndrome as a predictor of bacteraemia and outcome from sepsis.

Authors:  G R Jones; J A Lowes
Journal:  QJM       Date:  1996-07

9.  Benefit of appropriate empirical antibiotic treatment: thirty-day mortality and duration of hospital stay.

Authors:  Abigail Fraser; Mical Paul; Nadja Almanasreh; Evelina Tacconelli; Uwe Frank; Roberto Cauda; Sara Borok; Michal Cohen; Steen Andreassen; Anders D Nielsen; Leonard Leibovici
Journal:  Am J Med       Date:  2006-11       Impact factor: 4.965

10.  Decreases in procalcitonin and C-reactive protein are strong predictors of survival in ventilator-associated pneumonia.

Authors:  Renato Seligman; Michael Meisner; Thiago C Lisboa; Felipe T Hertz; Tania B Filippin; Jandyra M G Fachel; Paulo J Z Teixeira
Journal:  Crit Care       Date:  2006       Impact factor: 9.097

View more
  173 in total

1.  Monomer complexes of polyadenylic acid.

Authors:  R Jeremy; H Davies
Journal:  Biochem Soc Trans       Date:  1975       Impact factor: 5.407

2.  Antimicrobial management of intra-abdominal infections: literature's guidelines.

Authors:  Massimo Sartelli; Fausto Catena; Federico Coccolini; Antonio Daniele Pinna
Journal:  World J Gastroenterol       Date:  2012-03-07       Impact factor: 5.742

3.  Impact of inadequate empirical therapy on the mortality of patients with bloodstream infections: a propensity score-based analysis.

Authors:  Pilar Retamar; María M Portillo; María Dolores López-Prieto; Fernando Rodríguez-López; Marina de Cueto; María V García; María J Gómez; Alfonso Del Arco; Angel Muñoz; Antonio Sánchez-Porto; Manuel Torres-Tortosa; Andrés Martín-Aspas; Ascensión Arroyo; Carolina García-Figueras; Federico Acosta; Juan E Corzo; Laura León-Ruiz; Trinidad Escobar-Lara; Jesús Rodríguez-Baño
Journal:  Antimicrob Agents Chemother       Date:  2011-10-17       Impact factor: 5.191

4.  Death and kidney allograft dysfunction after bacteremia.

Authors:  Kenta Ito; Norihiko Goto; Kenta Futamura; Manabu Okada; Takayuki Yamamoto; Makoto Tsujita; Takahisa Hiramitsu; Shunji Narumi; Yoshihiro Tominaga; Yoshihiko Watarai
Journal:  Clin Exp Nephrol       Date:  2015-08-26       Impact factor: 2.801

Review 5.  Bloodstream infections in older patients.

Authors:  Dafna Yahav; Noa Eliakim-Raz; Leonard Leibovici; Mical Paul
Journal:  Virulence       Date:  2015-12-18       Impact factor: 5.882

6.  Randomized Noninferiority Trial of Cefoperazone-Sulbactam versus Cefepime in the Treatment of Hospital-Acquired and Healthcare-Associated Pneumonia.

Authors:  Jien-Wei Liu; Yen-Hsu Chen; Wen-Sen Lee; Jung-Chung Lin; Ching-Tai Huang; Hsi-Hsun Lin; Yung-Ching Liu; Yin-Ching Chuang; Hung-Jen Tang; Yao-Shen Chen; Wen-Chien Ko; Min-Chi Lu; Fu-Der Wang
Journal:  Antimicrob Agents Chemother       Date:  2019-07-25       Impact factor: 5.191

7.  Triage sepsis alert and sepsis protocol lower times to fluids and antibiotics in the ED.

Authors:  Geoffrey E Hayden; Rachel E Tuuri; Rachel Scott; Joseph D Losek; Aaron M Blackshaw; Andrew J Schoenling; Paul J Nietert; Greg A Hall
Journal:  Am J Emerg Med       Date:  2015-08-28       Impact factor: 2.469

8.  Compatibility of Ceftazidime-Avibactam, Ceftolozane-Tazobactam, and Piperacillin-Tazobactam with Vancomycin in Dextrose 5% in Water.

Authors:  Kevin Meyer; Maressa Santarossa; Larry H Danziger; Eric Wenzler
Journal:  Hosp Pharm       Date:  2017-03

9.  Gentamicin in hemodialyzed critical care patients: early dialysis after administration of a high dose should be considered.

Authors:  Anne Veinstein; Nicolas Venisse; Julie Badin; Michel Pinsard; René Robert; Antoine Dupuis
Journal:  Antimicrob Agents Chemother       Date:  2012-12-10       Impact factor: 5.191

10.  Appropriateness of empirical treatment and outcome in bacteremia caused by extended-spectrum-β-lactamase-producing bacteria.

Authors:  Florine N J Frakking; Wouter C Rottier; J Wendelien Dorigo-Zetsma; Jarne M van Hattem; Babette C van Hees; Jan A J W Kluytmans; Suzanne P M Lutgens; Jan M Prins; Steven F T Thijsen; Annelies Verbon; Bart J M Vlaminckx; James W Cohen Stuart; Maurine A Leverstein-van Hall; Marc J M Bonten
Journal:  Antimicrob Agents Chemother       Date:  2013-04-22       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.